A process for interconverting a mixture of cis-trans isomers of a compound of formula I into the substantially pure cis isomer.
Cis isomers of formula I are useful intermediates in the synthesis of cis isomers of benzamide piperidine compounds which exhibit activity as NK-1 receptor antagonists.
一种将化合物I的顺反异构体混合物相互转化为基本纯净的顺式异构体的过程。化合物I的顺式异构体是合成苯甲酰基
哌啶化合物的顺式异构体中间体,这些化合物表现出作为NK-1受体拮抗剂的活性。